Hilde Lindemann, former president of the American Society for Bioethics and Humanities, has resigned as a member of the editorial board of the American Journal of Bioethics. She wrote:
“While the journal has been hugely successful, there seems to be no oversight or accountability, so it is difficult for board members to know very much about the review process, the acceptance rate, the rate of submission, the journal’s financial footing, who owns (as opposed to publishes) the journal, and other matters having to do with its day-to-day operations. I do not know who sits on the conflict of interest committee even though the Information for Authors page says it is “comprised [sic] of members of the editorial board.” And although the editor-in-chief has said he would disclose the financials of the journal, he has not done so — at least, not to me. The board is never called to meet; we are never consulted as a group in any meaningful fashion. It’s not even clear who chooses the board, or on what basis. So it seems that our good names go toward a journal that we know very little about.
I have been an editor myself for much of my adult life and I know what the pressure of deadlines can do to distort editorial judgment. But I also know that it’s possible to run a journal transparently and responsibly, and I no longer feel confident that AJOB is so run. Until that changes, I cannot lend my name to its masthead.”
Science and Communications Officer, ANH-Intl
European Parliamentarians have refused to sign off the European Medicines Agency’s accounts, citing “grave” concerns
The MEPs are worried about the Agency’s lack of independence from pharmaceutical companies
The Nordic Cochrane Centre accuses the Agency of working to protect pharmaceutical profits
This is among several signs of MEPs increasingly questioning aspects of the European Union’s stance aspects relating to natural healthcare
Members of the European Parliament (MEPs) have bared their teeth in no uncertain manner over the independence of the European Medicines Agency (EMA), the body entrusted to determine the safety and effectiveness of drugs in the European Union (EU).
In a damning indictment of the EMA, of the type many people had despaired of ever witnessing in the closed environment of the European Parliament, an overwhelming majority of MEPs – 637 to 4! – voted not to sign off on the EMA’s accounts.
MEPs said that there appears to be no proper guarantee of the independence of experts hired to carry out scientific evaluations of pharmaceutical drugs. Furthermore, MEPs believe that some of the experts involved in evaluating drugs have conflicting interests and that the EMA’s hiring practices are dubious and indicate further conflicts of interest, in particular the way in which they get funding and spend public money.
American prosecutors are attempting to extradite a Danish scientist.
Poul Thorsen has been charged with 13 counts of wire fraud and nine counts of money laundering; a federal grand jury alleges that Thorsen stole over $1 million from autism research funding between February 2004 and June 2008.
Thorsen is said to have used the proceeds to buy a home in Atlanta, two cars and a Harley Davidson. He is said to have stolen the money while serving as the ‘principal investigator’ for a program that studied the relationship between autism and exposure to vaccines.
The Copenhagen Post reports:
“… [O]ver the four-year period he submitted over a dozen false invoices from the CDC for research expenses to Aarhus University, where he held a faculty position, instructing them to transfer the funds to a CDC account, which was in fact his personal account …
Thorsen’s research on autism is widely known in academic circles, where he was until this week a highly respected figure. A paper of his on the subject, which is known as ‘The Danish Study’, is quoted extensively to refute the autism vaccine connection.” And not forgetting Paul Offitt…
Attkisson had previously reported on the vaccine industry ties of Dr. Offit and others in a CBS Evening News report ‘How Independent Are Vaccine Defenders?
… Offit told the OC Register that he provided CBS News “the details of his relationship … with pharmaceutical company Merck”, but documents provided by CBS News indicate Offit did not disclose all of his financial relationships with Merck.